Table 1.
AP | Control | |
---|---|---|
Patients No. | 12 | 10 |
Age [years] | 67.4 ±11.6 | 70.0 ±9.5 |
Male/female | 9/4 | 5/6 |
Culprit | ||
LAD (cases) | 8 | |
LCX (cases) | 2 | |
RCA (cases) | 2 | |
CCS class | 2.1 ±0.7 | |
LVEF by QGS (%) | 64.0 ±13.7 | 70.4 ±10.5 |
BNP [pg/ml] | 55.1 ±21.0 | 26.5 ±15.4 |
Medications | ||
Anti-platelet | 12 | |
ACE-I | 1 | |
ARB | 2 | |
β-blockade | 4 | |
Ca-blockade | 3 | |
Nitroglycerin | 5 | |
Statin | 7 | 3 |
AP – angina pectoris, LAD – left anterior descending, LCX – left circumflex, RCA – right coronary artery, CCS – Canadian Cardiovascular Society, LVEF – left ventricular ejection fraction, QGS – quantitive gated SPECT, BNP – brain natriuretic peptide, ACE-I – angiotensin converting enzyme inhibitor, ARB – angiotensin receptor blockade, Ca – calcium. Some values are expressed as mean ± SD